MARKET

EOLS

EOLS

EVOLUS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.150
+0.110
+2.72%
Closed 16:00 03/31 EDT
OPEN
4.050
PREV CLOSE
4.040
HIGH
4.710
LOW
3.990
VOLUME
648.32K
TURNOVER
--
52 WEEK HIGH
29.40
52 WEEK LOW
3.115
MARKET CAP
139.97M
P/E (TTM)
-1.2863
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EOLS stock price target is 21.44 with a high estimate of 35.00 and a low estimate of 9.00.

EPS

EOLS News

More
  • Why These 7 Pharma Stocks Are Outplaying 90% Of The Stock Market
  • Investor's Business Daily · 20h ago
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37
  • The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
  • Benzinga · 03/11 12:05

Industry

Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About EOLS

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and patients a compelling value proposition with DWP-450. OnabotulinumtoxinA (BOTOX) is the neurotoxin approved 900 kDa botulinum toxin type A complex in the United States.
More

Webull offers kinds of Evolus Inc stock information, including NASDAQ:EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions.